Biosafety of Biological Drug Products Training Course :

Who Should Attend
Learning Objectives
Description
<strong>Course Schedule - June 4-5, 2009</strong><br/><br/>This course will introduce the unique perspectives and considerations of safety testing of biological drug products in contrast to typical safety testing of chemically-derived pharmaceuticals. Regulatory recommendations and requirements at each level of development will be outlined and accepted methods will be discussed in detail.<br><br> The course will also use the history of the last 25 years of safety assessment of biologically derived therapeutics and a case study approach to identifying current approach strengths, weaknesses and successful pathways.
01/13/2009 To 01/01/0001
Training Company
The Center for Professional Advancement (CfPA)
Industry
Clinical Research Organization
Course Category
Brochure Name
http://www.cfpa.com/PDF/2009/2228,C8-221,0906-103.pdf
Address
New Brunswick, NJ USA